Statement on Brexit by the Wellcome Sanger Institute, the European Molecular Biology Laboratory (EMBL) and the Francis Crick Institute
Statement on Brexit
Today marks the next chapter in the UK’s relationship with Europe. While we wait to see what a future relationship brings, researchers will continue to work across borders to tackle society’s most pressing problems, such as climate change, ageing and disease.
Science thrives when it has no boundaries and the Francis Crick Institute, the European Molecular Biology Laboratory (EMBL) and the Wellcome Sanger Institute are defined by our diversity and international nature.
One of EMBL’s six sites – the European Bioinformatics Institute – is located in the UK at the Wellcome Genome Campus, alongside the Sanger Institute.
All three institutions bring people together from diverse backgrounds, often across borders. This enhances science and will drive the continued success of research in the UK and Europe.
Whatever the outcome of Brexit, we will remain open and welcoming to scientists and students from around the world.
We all benefit from these collaborations, not just scientists. As we continue to work together across Europe, we can deliver greater benefits for people around the world.
Wellcome Sanger Institute
European Molecular Biology Laboratory (EMBL)
Francis Crick Institute
12 Apr 2021
New genetic drug target for treatment resistant colorectal cancer
Researchers have identified a new potential drug target for treating some types of advanced colorectal cancers.
7 Apr 2021
‘Patchwork’ tumours prevalent across multiple cancer types
Scientists have confirmed that tumour evolution is driven by changes that benefit the cancer, and these lead to a wide range ...